| Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study) | [1]Izabella Picinin Safe, [2]Marcus Lacerda, [3]Vitoria Silva Printes, [4]Adriana Ferreira Praia Marins, [5]Amanda Lia Rebelo Rabelo, [6]Amanda Araújo Costa, [7]Michel Araújo Tavares, [8]Jaquelane Silva Jesus, [9]Alexandra Brito Souza, [10]Francisco Beraldi-Magalhães, [11]Cynthia Pessoa Neves, [12]Wuelton Marcelo Monteiro, [13]Vanderson Souza Sampaio, [14]Eduardo P Amaral, [15]Renata Spener Gomes, [16]Bruno B Andrade, [17]Marcelo Cordeiro-Santos [Full author list] | PLOS One [curation] | DOI: 10.1371/JOURNAL.PONE.0235381 PubMed: 32589648 | acetylcysteine [curation]; phase II clinical trial [curation] | 2020-06-26 |